MicroRNA biomarkers of type 2 diabetes: A protocol for corroborating evidence by computational genomics and meta-analyses.
<h4>Background</h4>Few microRNAs were found consistently dysregulated in type 2 diabetes (T2D) that would gain confidence from Big Pharma to develop diagnostic or therapeutic biomarkers. This study aimed to corroborate evidence from eligible microRNAs-T2D association studies according to...
Saved in:
| Main Authors: | Hongmei Zhu, Siu-Wai Leung |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Public Library of Science (PLoS)
2021-01-01
|
| Series: | PLoS ONE |
| Online Access: | https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0247556&type=printable |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
MicroRNA-34, microRNA-130, microRNA-148, microRNA-181, microRNA-194 and microRNA-605 expression in colon cancer tissue
by: D. I. Azovsky, et al.
Published: (2024-03-01) -
Decreased Serum microRNA-21, microRNA-25, microRNA-146a, and microRNA-181a in Autoimmune Diabetes: Potential Biomarkers for Diagnosis and Possible Involvement in Pathogenesis
by: Yiwen Liu, et al.
Published: (2019-01-01) -
MicroRNA-21 versus microRNA-34: Lung cancer promoting and inhibitory microRNAs analysed in silico and in vitro and their clinical impact
by: Meik Kunz, et al.
Published: (2017-07-01) -
MicroRNA: a clinician's view of the state of the problem. Part 2. MicroRNA as a biomarker
by: O. Iu. Mironova, et al.
Published: (2023-05-01) -
MicroRNA - biomarker of aggressiveness of choroidal melanoma
by: A. F. Brovkina, et al.
Published: (2022-03-01)